And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | March 30, 2020

Industry Responds to COVID-19: Allergan Foundation; AG Hair; Revance

Allergan. Of the approximately $13 million in charitable grants the Allergan Foundation has awarded in 2020, a total of $2 million will be dedicated to more than 70 organizations responding to the local impact of the COVID-19...

Read More

News | March 28, 2020

Telehealth Webinar from Cosmetic Surgery Forum Explores Best Practices

As dermatologists deal with the evolving COVID-19 crisis, they are increasingly searching for guidance on the proper use of telemedicine. Joel Schlessinger, MD, Founder of Cosmetic Surgery Forum, brought together George Hruza, MD, past...

Read More

News | March 27, 2020

Evolve BioSystems and Janssen to Study the Impact of B. infantis EVC001 for AD Prevention in Infants

Evolve BioSystems, Inc. and Janssen Research & Development, LLC, are partnering to conduct a study looking at the potential role of B. infantis EVC001 in preventing early childhood atopic dermatitis (AD). The study will...

Read More

News | March 26, 2020

New AAAHC COVID-19 Guidelines Call for Postponing Elective or Non-Essential Visits and Surgeries

The Accreditation Association for Ambulatory Health Care (AAAHC) is calling for the postponement of elective or non-essential visits or surgeries in their newly released guidelines. For patients that require an office visit,...

Read More

News | March 26, 2020

Positive Phase 3 Results Reported for Medimetriks and Otsuka's AD Drug

Medimetriks Pharmaceuticals, Inc. and Otsuka Pharmaceuticals Co. Ltd.’s MM36 (difamilast) performed well in two Phase 3 Japanese clinical trials in adult and pediatric atopic dermatitis (AD) patients. Difamilast is a novel topical,...

Read More

Advertisement

The Latest News

Advertisement

View more